Stock Market News3 months AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS View Zacks
ABBV’s third-quarter 2024 earnings and sales beat estimates. The company increases the EPS guidance on encouraging product sales for immunology drugs.
XABBV’s third-quarter 2024 earnings and sales beat estimates. The company increases the EPS guidance on encouraging product sales for immunology drugs.
X